BIT/1HCA (BIT/1HCA)

Borsa Italiana: BIT/1HCA · EUR

€381

+0.80 (+0.2%)· Recorded snapshot

Market cap	87.4B
Revenue (ttm)	69.3B
Net income (ttm)	6B
EPS (ttm)	€27.2
P/E (trailing)	14.0x
P/E (forward)	15.1x
Dividend	€2.73 (0.72%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.3B
Net income (ttm): 6B
EPS (ttm): €27.2
P/E (trailing): 14.0x
P/E (forward): 15.1x
Market cap: 87.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E15.1

P25 n/aP50 n/aP75 n/a

Trailing P/E14

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC21.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BIT/1HCA indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-10-27
Employees	275,000
Employees change	4,000
Employees growth	1.27%
Enterprise value	EUR 136.8B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-10-10
Fiscal year end	December
Founded	1968
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	US40412C1018
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	EUR 87.4B
Next earnings date	2027-01-22
Price	EUR 380.90
Price currency	EUR
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-02
Symbol	bit/1HCA
Website	https://www.hcahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.9x
Average P/E ratio (3Y)	14.91x
Average P/E ratio (5Y)	13.5x
Earnings yield	7.13%
EV/Earnings	22.92x
EV/EBIT	12.57x
EV/EBITDA	9.03x
EV/FCF	26.01x
EV/Sales	1.94x
FCF / EV yield	3.85%
FCF yield	6.02%
Forward P/E	15.1x
Lynch fair value	EUR 129.98
Lynch upside	-65.88%
P/(FCF - SBC) ratio	17.83x
P/(OCF - SBC) ratio	9.22x
P/E ratio	14.02x
P/FCF ratio	16.62x
P/OCF ratio	8.89x
P/S ratio	1.26x
Price/EBITDA ratio	6.29x
Sector forward P/E	16.78x
Sector P/E	20.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.31%
EBITDA margin	20.06%
Effective tax rate	20.6%
FCF margin	7.43%
Gross margin	42.76%
Operating margin	15.31%
Pretax margin	12.48%
Profit margin	8.61%
Profit per employee	EUR 21,698
Profitable quarters	66
Profitable years	18
Revenue per employee	EUR 252,015
ROA	12.23%
ROA (5Y)	11.64%
ROCE	27.6%
ROIC	21.36%
ROIC (5Y)	19.69%
SBC / revenue	0.51%
Tax / revenue	2.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	17.06%
EPS growth (Q)	4.45%
EPS growth (QoQ)	-4.6%
EPS growth 10Y	16.95%
EPS growth 3Y	13.98%
EPS growth 5Y	9.12%
EPS growth quarters	6
EPS growth years	2
FCF growth	-26.22%
FCF growth (Q)	-0.77%
FCF growth (QoQ)	181.16%
FCF growth 3Y	10.93%
Gross profit growth	9.35%
Gross profit growth (Q)	5.38%
Gross profit growth 3Y	11.24%
Gross profit growth 5Y	8.44%
Net income growth	6.81%
Net income growth (Q)	-3.9%
Net income growth (QoQ)	-7.06%
Net income growth 3Y	5.83%
Net income growth 5Y	0.63%
Net income growth quarters	6
Net income growth years	2
OCF growth	-12.99%
OCF growth (Q)	1.02%
OCF growth (QoQ)	91.05%
OCF growth 10Y	7.32%
OCF growth 3Y	6.36%
OCF growth 5Y	30.66%
Operating income growth	3.6%
Operating income growth (Q)	-0.71%
Operating income growth 3Y	9.26%
Operating income growth 5Y	4.35%
Revenue growth	5.82%
Revenue growth (Q)	3.59%
Revenue growth (QoQ)	-1.88%
Revenue growth 10Y	6.71%
Revenue growth 3Y	7.61%
Revenue growth 5Y	6.3%
Revenue growth quarters	15
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -4.6B
Depreciation and amortization	EUR 3.4B
EBIT	EUR 10.6B
EBITDA	EUR 13.9B
EPS	EUR 27.17
Financing cash flow	EUR -4.6B
Free cash flow	EUR 5.3B
Free cash flow minus SBC	EUR 4.9B
Gross profit	EUR 29.6B
Income taxes	EUR 1.8B
Investing cash flow	EUR -5.3B
Net borrowing	EUR 5.2B
Net cash flow	EUR -78.4M
Net income	EUR 6B
Operating cash flow minus SBC	EUR 9.5B
Operating income	EUR 10.6B
Revenue	EUR 69.3B
Stock-based compensation	EUR 355.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR -32.75
Debt / EBITDA	3.12
Debt / FCF	8.78
Interest coverage	5.1
Long-term assets	EUR 41.3B
Long-term liabilities	EUR 42.1B
Net cash (debt)	EUR -45.4B
Net cash / market cap	-51.89%
Net debt / EBITDA	3.26
Net debt / FCF	8.63
Piotroski F-Score	6
Property, plant and equipment	EUR 31B
Shareholders' equity	EUR -4B
Tangible book value	EUR -17B
Tangible book value per share	EUR -78.15
Total assets	EUR 55.9B
Total cash	EUR 799.6M
Total debt	EUR 46.2B
Total liabilities	EUR 59.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.28
Current assets	EUR 14.6B
Current liabilities	EUR 17.8B
Current ratio	0.82
Inventory turnover	26.47
Net working capital	EUR 3.2B
Quick ratio	0.63
Working capital	EUR -3.1B
Working capital turnover	-22.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	8.7%
Dividend growth	8.76%
Dividend growth (3Y)	6.89%
Dividend growth (5Y)	10.9%
Dividend growth years	5
Dividend payment date	2026-12-29
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.73
Dividend yield	0.72%
Ex-dividend date	2026-12-14
Last dividend	EUR 0.70
Payout ratio	10.05%
Shareholder yield	9.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 370.40
1D price change	0.21%
1M price change	4.41%
1M total return	4.61%
1W price change	0.87%
1W total return	0.87%
1Y price change	5.43%
1Y return CAGR	6.15%
1Y total return	6.15%
20-day SMA	EUR 370.67
200-day SMA	EUR 383.26
3M price change	11.44%
3M total return	11.65%
3Y price change	63.06%
3Y return CAGR	18.6%
3Y total return	66.83%
50-day SMA	EUR 361.81
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 473.30
52-week high date	2026-03-12
52-week low	EUR 311.00
52-week low date	2026-07-14
5Y price change	78.83%
5Y return CAGR	13.27%
5Y total return	86.47%
6M price change	-6.57%
6M total return	-6.21%
All-time high	EUR 473.30
All-time high date	2026-03-12
All-time low	EUR 82.31
All-time low date	2020-06-25
Average true range (ATR)	EUR 4.62
Average volume	1.7
Change from 52-week high	-19.52%
Change from 52-week low	22.48%
Change from all-time high	-19.52%
Change from all-time low	362.76%
Change from open	0%
Day's gap	0.21%
High price	EUR 380.90
Low price	EUR 380.90
Monthly RSI	55.58
Open price	EUR 380.90
Previous close	EUR 380.10
Price vs 150-day SMA	2.84%
Price vs 20-day SMA	2.76%
Price vs 200-day SMA	-0.61%
Price vs 50-day SMA	5.28%
RSI	58.46
Sharpe ratio	0.17
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	0.43
Sortino ratio	0.4
Sortino ratio (3Y)	1.01
Sortino ratio (5Y)	0.75
Weekly RSI	54.48
YTD price change	-5.3%
YTD total return	-4.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144.3M
Shares change (QoQ)	-2.52%
Shares change (YoY)	-8.7%
Shares held by insiders	1.43%
Shares held by institutions	62.15%
Short ratio	3.7 days

Deeper analysis on BIT/1HCA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1HCA report

Is a complete BIT/1HCA research report available?

No complete published report is available for bit/1HCA (BIT/1HCA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1HCA (BIT/1HCA)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1HCA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1HCA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1HCA

Frequently asked questions